Aloxi Side Effects

Please note - some side effects for Aloxi may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Aloxi - for the Consumer

Aloxi

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Aloxi:

Constipation; headache; pain, swelling, or redness at the injection site; tiredness.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; trouble urinating; unusual muscle movement.

Aloxi Capsules

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Aloxi Capsules:

Constipation; headache; tiredness.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; trouble urinating; unusual muscle movement.

Aloxi Side Effects - for the Professional

Aloxi

The most common adverse reactions in chemotherapy-induced nausea and vomiting (incidence ≥ 5%) are headache and constipation (6.1)

The most common adverse reactions in postoperative nausea and vomiting (incidence ≥ 2%) are QT prolongation, bradycardia, headache, and constipation.

Side Effects by Body System

Cardiovascular

Cardiovascular side effects have been reported rarely. Bradycardia, hypotension, and nonsustained tachycardia have been reported in approximately 1% of patients in clinical trials. Hypertension, myocardial ischemia, extrasystoles, sinus tachycardia, sinus arrhythmia, supraventricular extrasystoles, and QT prolongation have been reported in less than 1% of patients. In many cases, causality was unclear.

Dermatologic

Dermatological side effects including allergic dermatitis (less than 1%) and rash (less than 1%) have been rarely reported.

Gastrointestinal

Gastrointestinal side effects have included constipation (2% to 5% or greater ) and diarrhea (1%). Appetite decrease, dyspepsia, abdominal pain, dry mouth, hiccups, and flatulence have been reported by less that 1% of patients in clinical trials.

General

General side effects have included reports of headache (2% to 9% or greater) and weakness (1%). Fatigue, fever, hot flash, and flu-like syndrome have been reported by less than 1% of patients in clinical trials.

Hepatic

Hepatic side effects occurred mainly in patients receiving highly emetogenic chemotherapy.

Hepatic side effects including transient, asymptomatic increases in AST and/or ALT and bilirubin have been reported in less than 1% of patients.

Metabolic

Metabolic side effects have included hyperkalemia (1%), electrolyte fluctuations, hyperglycemia, metabolic acidosis, and glycosuria.

Genitourinary

Genitourinary side effects have included urinary retention (less than 1%).

Psychiatric

Psychiatric side effects have included anxiety (1% to 2% or greater), anorexia (less than 1%), and euphoric mood (less than 1%).

Nervous system

Nervous system side effects including headache (2% to 9% or greater) and dizziness (1% to 2% or greater) have been reported. Insomnia, somnolence, hypersomnia, and paresthesia have been reported in less than 1% of patients.

Musculoskeletal

Musculoskeletal side effects have rarely included arthralgia (less than 1%).

Ocular

Ocular side effects including eye irritation and amblyopia have been reported in less than 1% of patients.

Local

Local side effects have included very rare cases of injection site reactions (burning, induration, discomfort, and pain) during postmarketing experience.

Other

Other side effects including fatigue and asthenia have been reported in greater than or equal to 2% of patients. Motion sickness, tinnitus, vein discoloration, and vein distention have been reported in less than 1% of patients.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.